Monoclonal antibodies (biology only) (HT only) common mistakes

Common mistakes

• Misunderstanding Delivery Mechanism

  Students often confuse how monoclonal antibodies deliver substances to cancer cells, thinking they directly kill the cells rather than targeting them for treatment.

  Fix itClarify that monoclonal antibodies bind specifically to cancer cell antigens, allowing for the delivery of a radioactive substance, toxic drug, or growth-inhibiting chemical directly to the cancer cells, which then disrupts their function.

• Misunderstanding unfamiliar tests

  Students often struggle to apply their knowledge of monoclonal antibodies to unfamiliar tests or treatments, leading to incorrect conclusions.

  Fix itTo improve, students should practice analyzing various scenarios involving monoclonal antibodies, focusing on the underlying principles and mechanisms, rather than memorizing specific examples.

• Misunderstanding Side Effects

  Students often believe that monoclonal antibodies have no side effects, focusing only on their benefits.

  Fix itEmphasize the importance of discussing both the potential side effects and benefits of monoclonal antibodies in treatments to provide a balanced understanding.

• Overlooking Ethical Considerations

  Students often fail to adequately discuss the ethical issues related to the use of monoclonal antibodies, focusing only on advantages and disadvantages.

  Fix itTo improve, students should ensure they include specific ethical considerations, such as animal testing and the implications of using human cells in research, alongside their evaluation of advantages and disadvantages.